Press Releases 2012

First Mobile Application for Bioanalytical Assays in the Industry
Dr. Susan Stansfield, Joins inVentiv Health as Executive Vice President, Clinical Operations
PharmaNet/i3 to Present Scientific Posters at the 2012 American Association of Pharmaceutical Scientists (AAPS)
Jamil Hantash Joins PharmaNet/i3 As Director of Immunochemistry Operations
PharmaNet/i3 Announces Bioanalytical Webinar Series
PharmaNet/i3 will be holding a series of complimentary webinars on topics related to bioanalytical innovations in drug development.
Sarajane Mackenzie Joins PharmaNet/i3 as Senior Vice President, Human Resources
Sarajane Mackenzie has been appointed Senior Vice President, Human Resources to lead the global Human Resources function, including talent engagement, human resources operations, total rewards, and professional development.
Dr Robert Lasser Joins PharmaNet/i3 as Vice President and General Manager, Neuroscience
PharmaNet/i3 announced today that Robert Lasser, MD, MBA, has been appointed Vice President and General Manager, Neuroscience, overseeing the management of all clinical projects handled by PharmaNet/i3’s Neuroscience group and the Rater Training Services team.
PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
PharmaNet/i3 announced the launch of PharmaNet/i3 Strategic Resourcing, a new unified provider of staffing and functional service provider (FSP) services.
PharmaNet/i3 Expands Configurable Randomization and Trial Supply Management Solution Offering
Custom IRT Solutions Deliver Optimal Study Operating Efficiencies and Logistics
PharmaNet/i3 to Showcase Unified Brand at DIA 2012
PharmaNet/i3 announced it will participate at DIA 2012 in Philadelphia from June 24-28, 2012. Experts from PharmaNet/i3 will address some of the latest drug development outsourcing trends during several DIA program sessions.
PharmaNet/i3 Receives Distinguished Partner Award from the US Chinese Anti-Cancer Association
PharmaNet/i3 has been named the recipient of the US Chinese Anti-Cancer Association (USCACA) Distinguished Partner Award for its support of oncology clinical trials and cancer research in China.
ASLAN Pharmaceuticals Selects PharmaNet/i3 as Strategic Partner For Oncology Development
PharmaNet/i3 announced today that ASLAN Pharmaceuticals has selected PharmaNet/i3 as a Strategic Partner supporting the development of their oncology portfolio in Asia, and conducting Phase I and Phase II clinical trials for two of ASLAN’s compounds.
Stephan Henauer to Head i3 Pharma Resourcing in Central, Eastern and Northern Europe
PharmaNet/i3 announced today that it has appointed Stephan Henauer, M.D., as Executive Director, i3 Pharma Resourcing. In this role, Dr. Henauer will provide leadership for PharmaNet/i3’s Staffing Business in Central, Eastern and Northern Europe.
PharmaNet/i3 Announces the Opening of the 6th Edition of the Survey on Observational Research
PharmaNet/i3 announces the opening of the 6th Edition of the Survey on Observational Research. The survey is designed to enhance the understanding of observational research among sponsors, regulators, policymakers, physicians and patients.